Aringer, M <br/><br/>
Current state of evidence on 'off-label' therapeutic options for systemic lupus erythematosus, including biological immunosuppressive agents, in Germany, Austria and Switzerland--a consensus report.  [electronic resource] 

 -  Lupus  Apr 2012 
 - 386-401 p.  digital 
<br/><br/> Publication Type: Journal Article; Practice Guideline; Review; Systematic Review 
<br/><br/><label>ISSN: </label>1477-0962 
<br/><br/><label>Standard No.: </label>10.1177/0961203311426569  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Austria<br/>Biological Products--adverse effects<br/>Consensus<br/>Evidence-Based Medicine--standards<br/>Germany<br/>Humans<br/>Immunosuppressive Agents--adverse effects<br/>Lupus Erythematosus, Systemic--complications<br/>Off-Label Use--standards<br/>Patient Selection<br/>Risk Assessment<br/>Risk Factors<br/>Switzerland<br/>Treatment Outcome